Clinical Genetics Automation – Where are we Now? – (press release) (registration)

Clinical Genetics Automation – Where are we Now? (press release) (registration)
However, the increasing demand for molecular tests by clinicians has put increased demand on routine laboratories to be able to carry out in-house clinical genetics automated testing. Not only that, there is a requirement for increased turn-around

and more »

Genetics – Google News

Myriad Genetics to Present at the 2016 Goldman Sachs Healthcare Conference
GlobeNewswire (press release)
SALT LAKE CITY, June 06, 2016 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Mark C. Capone, president and CEO, is scheduled to present at the Goldman Sachs Healthcare Conference at 10:00 a.m. Pacific on June …
Myriad Genetics (MYGN) to Present Positive Data on myRisk Hereditary Cancer Test at
MYRIAD GENETICS INC. (NASDAQ:MYGN) Financial Condition Compared to S&P 500CML News
Were Analysts Bullish Myriad Genetics, Inc. (NASDAQ:MYGN) This Week?Franklin Independent
Sonoran Weekly Review
all 13 news articles »

Genetics – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *